From Lag to Live: The FDA's Real-Time Clinical Trial Initiative and What It Means for Health AI
Enes Hosgor
Gesund resources
Webinars & conversations.
Interviews, webinars and conversations from the Gesund archive.
Explore all resources →Insights & publications
The library.
Articles, research, announcements and perspectives. Choose a type or search by topic, title or author.
Showing 8 of 8 matching resources
Explore →
Paying for Intelligence: The Challenges and Opportunities of CMS Reimbursement for AI in Healthcare
Enes Hosgor
FDA denied the Harrison.ai petition. The bigger signal is what comes next for clinical AI
Enes Hosgor
FDA’s QMSR Is Live: Why Clinical AI Teams Need Inspection-Ready Evidence, Not Just Great Models
Enes Hosgor
Medical Superintelligence Arrives: What Microsoft’s MAI DxO Means for Regulatory Grade Healthcare AI
Enes Hosgor
The FDA Is Now Using Generative AI to Review Drugs and Devices. Here’s What That Means for You.
Enes Hosgor
How to bring more trust and transparency to clinical AI
Enes Hosgor · Smit Patel · STAT+
Auto-machine learning for opportunistic thyroid nodule detection in lung cancer screening chest CT.
Sumir Patel · Veysel Kocaman · Mehmet Burak Sayici · Nikhil Patel
Radiology captures the tension between AI’s potential and concern for patients
Katie Palmer · STAT+
Four types of bias in medical AI are running under the FDA’s radar
Enes Hosgor · Oguz Akin · STAT+
Merck Invests in Gesund, Launches Medical AI Platform on AWS
Syed Hamza Sohail
‘I need evidence yesterday’: Gesund raises $2 million to provide algorithm-validating data
Emma Betuel
An automated approach for machine learning model performance analysis on sub cohorts to assess for biases
Brian Ayers · Ray Funahashi · Veysel Kocaman · Enes Hosgor
No matching resources. Try another type or search.